What changed in this filing

/stocks — the workspaceLOADING

Item 1. Financial Statements

2025-12-29 compared with 2025-12-29 · 124 added, 123 removed, 986 unchanged (20% of the section changed)

1 unchanged sentence

TECHNOLOGIES INC.

CONSOLIDATED INTERIM BALANCE SHEETS AT SEPTEMBER 30, 2025 (Unaudited)

CONSOLIDATED INTERIM BALANCE SHEETS AT JUNE 30, 2025 (Unaudited)

AND DECEMBER 31, 2024 (Audited)

16 unchanged sentences

– Series A, 50,000,000 shares authorized, $ 0.001 par value per share, stated value $ 100 per share, 100,000 shares designated,

No shares issued and outstanding, September 30, 2025 and December 31, 2024, respectively (Note 9)

No shares issued and outstanding, June 30, 2025 and December 31, 2024, respectively (Note 9)

Stock - Series C, $ 0.001 par value;

stated value $ 100 per share, 10,000 shares designated, No issued and outstanding, September

stated value $ 100 per share, 10,000 shares designated, No issued and outstanding, June

30, 2025 and December 31, 2024, respectively (Note 9)

2 unchanged sentences

Preferred Stock - Series B, $ 0.001

shares designated, 100 shares issued and outstanding, September 30, 2025 and December 31, 2024, respectively (Note 9)

shares designated, 100 shares issued and outstanding, June

30, 2025 and December 31, 2024, respectively (Note 9)

Preferred Stock - Series D, $ 0.001 par value;

convertible, stated value $ 3.32 per share, 230,000 shares designated, 155,000 shares issued and outstanding, September 30,

convertible, stated value $ 3.32 per share, 230,000 shares designated, 155,000 shares issued and outstanding, June 30, 2025

and December 31, 2024, respectively (Note 9)

Preferred Stock- Series E, $ 0.001 par value;

convertible, stated value $ 1,000 per share, 1,000 shares designated, 0 Nil issued and outstanding, September 30, 2025 and December

convertible, stated value $ 1,000 per share, 1,000 shares designated, 0 Nil issued and outstanding, June 30, 2025 and December

31, 2024, respectively;

Preferred Stock - Series E-1, $ 0.001 par value;

convertible, stated value $ 0.87 per share, 1,152,500 shares designated, 1,152,500 shares issued and outstanding, September

convertible, stated value $ 0.87 per share, 1,152,500 shares designated, 1,152,500 shares issued and outstanding, June 30,

2025 and December 31, 2024, respectively (Note 9)

2 unchanged sentences

per share, 1,000

shares designated, 0 Nil issued and outstanding, December 31, 2024 and 2023, respectively

shares designated, 0 Nil issued and outstanding, December

31, 2024 and 2023, respectively (Note 9)

Preferred Stock - Series G, $ 0.001

1 unchanged sentence

per share, 4,600

shares designated, 0 Nil issued and outstanding, September 30, 2025 and December

31, 2024, respectively (Note 9);

shares designated, 0 Nil issued and outstanding, June 30, 2025 and December 31, 2024, respectively (Note 9);

Preferred Stock – Series H, $ 0.001 par

convertible, stated value $ 1 per share, 39,895 shares designated, 39,895 issued and outstanding, September 30, 2025

and December 31, 2024, respectively (Note 9)

convertible, stated value $ 1 per share, 39,895 shares designated, 39,895 issued and outstanding, June 30, 2025 and

December 31, 2024, respectively (Note 9)

Common Stock - $ 0.001 par value;

6,000,000,000

shares authorized, 1,603,095,243 shares issued and outstanding, September 30, 2025 and December 31, 2024, respectively (Note

shares authorized, 1,603,095,243 shares issued and outstanding, June 30, 2025 and December 31, 2024, respectively (Note 9)

Additional Paid

5 unchanged sentences

CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS FOR THE THREE AND

NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024 (Unaudited)

SIX MONTHS ENDED JUNE 30, 2025 AND 2024 (Unaudited)

expressed in United States Dollars (“US$ or $”), except for number of shares)

Operating Expenses

General and administrative

and administrative

Professional fees

2 unchanged sentences

Other income (expenses)

Amortized expense (Notes 5, 6 and 7)

Interest expense (Notes 5, 6 and 7)

Amortized expense (Notes 5,

Interest expense (Notes 5,

Total other expense

10 unchanged sentences

CONSOLIDATED INTERIM STATEMENTS OF MEZZANINE EQUITY AND

STOCKHOLDERS’ DEFICIENCY

FOR THE THREE AND NINE ENDED SEPTEMBER 30, 2025 AND 2024

the Three and Nine Months Ended September 30, 2025 and 2024

STOCKHOLDERS’ DEFICIENCY FOR THE THREE AND SIX ENDED JUNE 30, 2025 AND

the Three and Six Months Ended June 30, 2025 and 2024

expressed in United States Dollars (“US$ or $”), except for number of shares)

3 unchanged sentences

Net loss for the

Balance, September

Balance, June

1,603,095,243

Balance, July 1, 2025

Balance, April 1, 2025

1,603,095,243

Net loss for the

Balance, September

Balance, June

1,603,095,243

2 unchanged sentences

Net loss for the

Balance, September

Balance, June

1,603,095,243

Balance, July

Balance, April

1,603,095,243

Balance, September

Balance, June

1,603,095,243

2 unchanged sentences

CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS FOR THE

NINE MONTHS ENDED SEPTEMBER

30, 2025 AND 2024 (Unaudited)

SIX MONTHS ENDED JUNE 30, 2025 AND 2024 (Unaudited)

expressed in United States Dollars (“US$ or $”), except for number of shares)

15 unchanged sentences

Loan from a principal shareholder

Net cash provided

by financing activities

Net cash provided by financing

Net increase (decrease) in cash

15 unchanged sentences

concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business.

For the period ended September 30, 2025, we generated no revenues from operations, incurred a net loss of $ 2,074,314 (September

30, 2024 - $ 2,130,550 ) and had a working capital deficit of $ 22,460,609 (December 31, 2024 - $ 20,386,294 ).

and an accumulated deficit of $ 22,460,609 (December 31,

2024 - $ 20,386,294 ).

It is management’s opinion that these matters raise substantial doubt about our ability to continue

as a going concern for a period of twelve months from the issuance date of these unaudited condensed consolidated interim financial

Our ability to continue as a going concern is dependent upon management’s ability to raise additional capital

as needed from the sales of stock or debt and further implement our business plan.

However, the Company may not be able to secure

such financing in a timely manner or on favourable terms, if at all.

Furthermore, if the Company issues equity securities to raise

additional funds, its existing stockholders may experience dilution, and the new equity securities may have rights, preferences

and privileges senior to those of the Company’s existing stockholders.

The accompanying unaudited condensed consolidated

interim financial statements do not include any adjustments that might be required should we be unable to continue as a going

For the period ended June 30, 2025, we generated no revenues from operations, incurred a net loss of $ 1,427,959 (June 30, 2024 -

$ 1,504,104 ) and had a working capital deficit of $ 21,814,254 (December 31, 2024 - $ 20,386,294 ) and an accumulated deficit of $ 33,086,086 (December 31, 2024 - $ 31,658,127 ).

management’s opinion that these matters raise substantial doubt about our ability to continue as a going concern for a period

of twelve months from the issuance date of these unaudited condensed consolidated interim financial statements.

Our ability to

continue as a going concern is dependent upon management’s ability to raise additional capital as needed from the sales

of stock or debt and further implement our business plan.

However, the Company may not be able to secure such financing in a timely

manner or on favourable terms, if at all.

Furthermore, if the Company issues equity securities to raise additional funds, its

existing stockholders may experience dilution, and the new equity securities may have rights, preferences and privileges senior

to those of the Company’s existing stockholders.

The accompanying unaudited condensed consolidated interim financial statements

do not include any adjustments that might be required should we be unable to continue as a going concern.

3 Summary of Significant Accounting Policies

14 unchanged sentences

The Company’s fiscal year-end is December 31.

unaudited condensed consolidated interim financial statements include the accounts of the Company and its wholly owned subsidiary.

Significant intercompany accounts and transactions have been eliminated.

The unaudited condensed consolidated

interim financial statements include the accounts of the Company and its wholly owned subsidiary.

Significant intercompany accounts

and transactions have been eliminated.

accounting estimates and assumptions

96 unchanged sentences

Topic 260-10 which provides for calculation of “basic” and “diluted” earnings per share.

loss per share of common stock is computed by dividing net loss $ 2,074,314 [2024 - $ 2,130,550 ] from continuing operation by the

weighted average number of shares of common stock 1,603,095,243 [2024 - 1,603,095,243 ], outstanding during the respective nine-month

loss per share of common stock is computed by dividing net loss $ 1,427,959 [2024 - $ 1,504,104 ] from continuing operation by the weighted

average number of shares of common stock 1,603,095,243 [2024 - 1,603,095,243 ], outstanding during the respective six-month periods.

loss per share of common stock is computed similarly to basic loss per share from continuing operations except the weighted average

62 unchanged sentences

from investors for additional, more detailed information about a reportable segment’s expenses.

The Company adopted quarterly

requirements of this guidance beginning in the first quarter of 2025 and the adoption has no material impact on the unaudited condensed interim consolidated financial

The Company is required to

adopt the guidance in the fourth quarter of fiscal 2025, though early adoption is permitted.

The Company adopted quarterly requirements

of this guidance beginning in the first quarter of 2025 and the adoption has no material impact on the unaudited condensed interim consolidated financial

accounting guidance not yet adopted

6 unchanged sentences

impact of this amendment on its consolidated financial statements.

January 2025, the FASB issued a clarification by ASU 2025-01 Income Statement - Expense Disaggregation Disclosures (Topic

A new guidance related to expense disaggregation disclosures.

This guidance requires additional disclosure of certain amounts

included in the expense captions presented in the Statement of Income as well as disclosures about selling expenses.

The new guidance

will be effective for us beginning in 2027 on an annual basis and in the first quarter of 2028 on a quarterly basis and may be

applied on either a prospective or retrospective basis.

In January 2025, the FASB issued a clarification by ASU 2025-01 Income Statement - Expense Disaggregation Disclosures (Topic 220):

A new guidance related

to expense disaggregation disclosures.

This guidance requires additional disclosure of certain amounts included in the expense

captions presented in the Statement of Income as well as disclosures about selling expenses.

The new guidance will be effective

for us beginning in 2027 on an annual basis and in the first quarter of 2028 on a quarterly basis and may be applied on either

a prospective or retrospective basis.

Early adoption of the guidance is permitted.

The Company is currently

evaluating the effect this new guidance will have on our disclosures.

The Company is currently evaluating the effect

this new guidance will have on our disclosures.

Company continues to evaluate the impact of the new accounting pronouncement, including enhanced disclosure requirements, on our

1 unchanged sentence

4 Accounts Payable and Accrued Liabilities

payable and accrued liabilities as of September 30, 2025 and December 31, 2024 are summarized below:

payable and accrued liabilities as of June 30, 2025 and December 31, 2024 are summarized below:

of Accounts Payable and Accrued Liabilities

39 unchanged sentences

the promissory note using the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 34,028 and $ 34,028 , respectively,

in the condensed consolidated interim statements of operations.

As of September 30, 2025 and December 31, 2024, $ 500,000 in principal

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 33,658 and $ 33,658 , respectively, in

the condensed consolidated interim statements of operations.

As of June 30, 2025 and December 31, 2024, $ 500,000 in principal

was outstanding.

9 unchanged sentences

fee payable of $ 15,000 was amortized to consolidated statements of operation over the term of the promissory note.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 10,396 and $ 10,396 , respectively,

in the condensed consolidated interim statements of operations.

of September 30, 2025 and December 31, 2024, $ 165,000 in principal was outstanding.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 10,283 and $ 10,283 , respectively, in

the condensed consolidated interim statements of operations.

of June 30, 2025 and December 31, 2024, $ 165,000 in principal was outstanding.

On January 14, 2022,

8 unchanged sentences

fee payable of $ 15,000 was amortized to consolidated statements of operations over the term of the promissory note.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 9,452 and $ 9,452 , respectively,

in the condensed consolidated interim statements of operations.

of September 30, 2025 and December 31, 2024, $ 150,000 in principal was outstanding.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 9,349 and $ 9,349 , respectively, in the

condensed consolidated interim statements of operations.

of June 30, 2025 and December 31, 2024, $ 150,000 in principal was outstanding.

On April 27, 2022,

10 unchanged sentences

of the note was amortized to consolidated statements of operations over the term of the promissory note using the effective interest

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 6,301 and $ 6,301 , respectively,

in the condensed consolidated interim statements of operations.

As of September 30, 2025 and December 31, 2024, $ 125,000 in principal

was outstanding.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 6,233 and $ 6,233 , respectively, in the

condensed consolidated interim statements of operations.

As of June 30, 2025 and December 31, 2024, $ 125,000 in principal was

notes issued during year ended December 31, 2023

5 unchanged sentences

Upon the occurrence of an event of default, the promissory note accrued default interest at an annual rate of 22 %.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 6,846 and $ 6,846 , respectively,

in the condensed consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 6,771 and $ 6,771 , respectively, in the

condensed consolidated interim statements of operations.

6 Convertible Notes

34 unchanged sentences

as market data becomes available.

convertible notes payable, all of which are liabilities as of September 30, 2025 and December 31, 2024, are as follows:

convertible notes payable, all of which are liabilities as of June 30, 2025 and December 31, 2024, are as follows:

Principal outstanding

7 unchanged sentences

Those convertible notes matured on December 31, 2022.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 43,103 and $ 43,103 respectively,

in the condensed consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 42,634 and $ 42,634 respectively, in the

condensed consolidated interim statements of operations.

notes issued during year ended December 31, 2022

5 unchanged sentences

The convertible note matured on December 31, 2022.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 4,537 and $ 4,537 respectively, in

the condensed consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 4,487 and $ 4,487 respectively, in the

condensed consolidated interim statements of operations.

notes issued during year ended December 31, 2022

13 unchanged sentences

the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 17,104 and $ 17,104 respectively,

in the condensed consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 16,829 and $ 16,829 respectively, in the

condensed consolidated interim statements of operations.

notes issued during year ended December 31, 2023

13 unchanged sentences

were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 9,426 and $ 9,426 , respectively,

in the condensed consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 9,324 and $ 9,324 , respectively, in the

condensed consolidated interim statements of operations.

January 10, 2023, the Company issued a convertible note with a principal amount and cash proceeds of $ 110,000 .

5 unchanged sentences

The note is in default.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 426 and $ 9,426 , respectively, in

the condensed consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 11,220 and $ 9,324 , respectively, in the

condensed consolidated interim statements of operations.

notes issued during year ended December 31, 2022

13 unchanged sentences

were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 7,808 and $ 7,808 in the condensed

consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 7,723 and $ 7,723 in the condensed consolidated

interim statements of operations.

February 11, 2022, the Company issued a convertible note with a principal amount of $ 137,500 for cash proceeds of $ 125,000 .

12 unchanged sentences

were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 11,523 and $ 11,523 in the condensed

consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 11,397 and $ 11,397 in the condensed consolidated

interim statements of operations.

notes issued during year ended December 31, 2022

15 unchanged sentences

interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 9,426 and $ 9,426 in the condensed

consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 9,324 and $ 9,324 in the condensed consolidated

interim statements of operations.

June 24, 2022, the Company issued a convertible note with a principal amount of $ 110,000 for cash proceeds of $ 100,000 .

13 unchanged sentences

were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 9,426 and $ 9,426 in the condensed

consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 9,324 and $ 9,324 in the condensed consolidated

interim statements of operations.

notes issued during year ended December 31, 2022

14 unchanged sentences

were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 7,072 and $ 7,072 in the condensed

consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 6,995 and $ 6,995 in the condensed consolidated

interim statements of operations.

May 5, 2022, the Company issued a convertible note with a principal amount of $ 110,000 for cash proceeds of $ 100,000 .

13 unchanged sentences

were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 9,218 and $ 9,218 in the condensed

consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 9,118 and $ 9,118 in the condensed consolidated

interim statements of operations.

October 14, 2022, the Company issued a convertible note with a principal amount of $ 110,000 for cash proceeds of $ 110,000 .

10 unchanged sentences

the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 7,485 and $ 7,485 in the condensed

consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 7,404 and $ 7,404 in the condensed consolidated

interim statements of operations.

December 15, 2022, the Company issued a convertible note with a principal amount of $ 220,000 for cash proceeds of $ 200,000 .

12 unchanged sentences

were being amortized to consolidated statements of operations over the term of the convertible note using the effective interest

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 18,854 and $ 18,854 in the condensed

consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 18,649 and $ 18,649 in the condensed consolidated

interim statements of operations.

notes issued during year ended December 31, 2023

5 unchanged sentences

The convertible note matured on December 31, 2023.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 1,715 and $ 1,715 , respectively,

in the condensed consolidated interim statements of operations.

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 1,696 and $ 1,696 , respectively, in the

condensed consolidated interim statements of operations.

notes issued during year ended December 31, 2022

6 unchanged sentences

of operations over the term of the convertible note using the effective interest method.

the three months ended September 30, 2025 and 2024, the Company recorded interest expense of $ 1,664 and $ 1,664 in the consolidated

the three months ended June 30, 2025 and 2024, the Company recorded interest expense of $ 1,645 and $ 1,645 in the consolidated

statements of operations.

63 unchanged sentences

Balance at December

Company recorded interest expenses of $ 365,999 and $ 365,999 for the three months ended September 30, 2025 and 2024, respectively.

interest payable on senior secured notes as on September 30, 2025 and December 31, 2024 amounts to $ 7,496,891 and $ 6,398,894 respectively.

Company recorded interest expenses of $ 365,999 and $ 365,999 for the three months ended June 30, 2025 and 2024, respectively.

interest payable on senior secured notes as on June 30, 2025 and December 31, 2024 amounts to $ 7,126,870 and $ 6,398,894 respectively.

8 Related Party

at September 30, 2025 and December 31, 2024, respectively, $ 551,089 and $ 394,617 was due to principal shareholder.

were received to support the Company’s working capital requirement, and it is unsecured, non-interest bearing and payable

at June 30, 2025 and December 31, 2024, respectively, $ 523,307 and $ 394,617 was due to principal shareholder.

This amounts were

received to support the Company’s working capital requirement, and it is unsecured, non-interest bearing and payable on demand.

9 Stockholders’ Deficiency

of September 30, 2025 and December 31, 2024, the Company is authorized to issue 50,000,000 shares of preferred stock, with designations,

of June 30, 2025 and December 31, 2024, the Company is authorized to issue 50,000,000 shares of preferred stock, with designations,

voting, and other rights and preferences to be determined by our Board of Directors, of which 48,460,905 remain available for

30 unchanged sentences

The number of Series A Preferred Stock issued

and outstanding as of September 30, 2025 and December 31, 2024 was Nil .

and outstanding as of June 30, 2025 and December 31, 2024 was Nil .

July 28, 2020, the Company filed a certificate of designations of Series B Super Voting Preferred Stock (the “Certificate

47 unchanged sentences

options issued expired without exercise.

number of Series B Preferred Stock issued and outstanding as of September 30, 2025 and December 31, 2024 was 100 .

number of Series B Preferred Stock issued and outstanding as of June 30, 2025 and December 31, 2024 was 100 .

C Preferred Stock

18 unchanged sentences

Company did not issue Series C Preferred Stock.

As at September 30, 2025 and December 31, 2024, no shares of Series C Preferred Stock

As at June 30, 2025 and December 31, 2024, no shares of Series C Preferred Stock

are outstanding.

22 unchanged sentences

shares of its Common Stock.

As of September 30, 2025 and December 31, 2024, 155,000 shares of Series D Preferred Stock remain unconverted

As of June 30, 2025 and December 31, 2024, 155,000 shares of Series D Preferred Stock remain unconverted

and outstanding.

48 unchanged sentences

derivative liabilities during year ended December 31, 2021.

As at September 30, 2025 and December 31, 2024, no shares of Series E Preferred

As at June 30, 2025 and December 31, 2024, no shares of Series E Preferred

Stock are outstanding.

As of September 30, 2025 and December 31, 2024, 1,152,000 shares of Series E-1 Preferred Stock are outstanding.

As of June 30, 2025 and December 31, 2024, 1,152,000 shares of Series E-1 Preferred Stock are outstanding.

F Preferred Stock

19 unchanged sentences

October 11, 2021, the 1,000 shares of Series F Preferred Stock were converted into 192,073,017 shares of Common Stock.

As of September

30, 2025 and December 31, 2024, Nil shares of Series F Preferred Stock were issued and outstanding

59 unchanged sentences

value with the remaining $ 39,855 reclassified into in additional paid-in capital.

September 30, 2025 and December 31, 2024, 39,895 shares of Series H Preferred Stock remain outstanding.

issuances of Common Stock occurred in the nine months ended September 30, 2025 and year ended December 31, 2024.

June 30, 2025 and December 31, 2024, 39,895 shares of Series H Preferred Stock remain outstanding.

issuances of Common Stock occurred in the six months ended June 30, 2025 and year ended December 31, 2024.

August 14, 2021, our shareholders approved an increase in the authorized number of shares of Common Stock to 6,000,000,000, from

5 unchanged sentences

Warrant values per share ranged from $0.023 to $0.002.

For the nine months ended September 30, 2025, a summary of

For the six months ended June 30, 2025, a summary of

our warrant activity is as follows:

3 unchanged sentences

Outstanding and

exercisable at September 30, 2025

exercisable at June 30, 2025

determining the fair value of these equity-classified features, the Company considered the fact that its common stock is quoted

32 unchanged sentences

Company has evaluated subsequent events through December 23, 2025, the date the financial statements were available to be issued.

to September 30, 2025, the Company received $ 186,257 in additional funding from its principal shareholder, Arena.

to June 30, 2025, the Company received $ 214,039 in additional funding from its principal shareholder, Arena.

These funds were

4 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1. Financial Statements